APA (7th ed.) Citation

A, A., LM, C., JS, F., W, T., 2nd, C. J., M, K., . . . D, B. (2021). Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer. Cancers, 13(4), . https://doi.org/10.3390/cancers13040677

Chicago Style (17th ed.) Citation

A, Araujo, et al. "Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer." Cancers 13, no. 4 (2021). https://doi.org/10.3390/cancers13040677.

MLA (9th ed.) Citation

A, Araujo, et al. "Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer." Cancers, vol. 13, no. 4, 2021, https://doi.org/10.3390/cancers13040677.